Antifungal activity of mycogenic silver nanoparticles on clinical yeasts and phytopathogens

Registo de metadados completa
Campo DCValoridioma
dc.contributor(LDI) Lab. Desenvolvimento e Inovação Industrialpt_BR
dc.contributor.authorRibeiro, Luiz Gustavopt_BR
dc.contributor.authorRoque, Gabriella Sales Calaçopt_BR
dc.contributor.authorConrado, Rafaelpt_BR
dc.contributor.authorSouza, Ana Olívia dept_BR
dc.date.accessioned2023-01-11T18:19:39Z-
dc.date.available2023-01-11T18:19:39Z-
dc.date.issued2023pt_BR
dc.identifier.citationRibeiro LG, Roque GSC, Conrado R, Souza AO. Antifungal activity of mycogenic silver nanoparticles on clinical yeasts and phytopathogens. Antibiotics. 2023 Jan; 12(1):91. doi:10.3390/antibiotics12010091.pt_BR
dc.identifier.urihttps://repositorio.butantan.gov.br/handle/butantan/4761-
dc.description.abstractIn this study, seven different silver nanoparticles (AgNPs) were obtained using the fungi species from the phylum Ascomycota, Aspergillus tubingensis, Aspergillus spp., Cladosporium pini-ponderosae, Fusarium proliferatum, Epicoccum nigrum, Exserohilum rostratum, and Bionectria ochroleuca, isolated from the Brazilian biodiversity, particularly from the mangrove and Caatinga biomes. The nanoparticles were coded as AgNP-AT, AgNP-Asp, AgNP-CPP, AgNP-FP, AgNP-EN, AgNP-ER, and AgNP-BO and characterized using spectrophotometry (UV-Vis), dynamic light scattering (DLS), zeta potential, transmission electron microcopy (TEM), and Fourier-transform infrared (FTIR) spectroscopy. All the AgNPs presented homogeneous size in the range from 43.4 to 120.6 nm (DLS) and from 21.8 to 35.8 nm (TEM), pH from 4.5 to 7.5, negative charge, and presence of protein coating on their surface. The antifungal activity of the AgNPs was evaluated on clinical strains of Candida albicans, and on the non-albicans species, Candida krusei, Candida glabrata, Candida parapsilosis, Candida tropicalis, and Candida guilliermondii, common in hospital infections, and against the phytopathogens Fusarium oxysporum, Fusarium phaseoli, Fusarium sacchari, Fusarium subglutinans, Fusarium verticillioides, and Curvularia lunata, which are species responsible for serious damage to agriculture production. The AgNPs were effective against the yeasts with MICs ranging from 1.25 to 40 µM and on the phytopathogens with MICs from 4 to 250 µM, indicating the promising possibility of application of these AgNPs as antifungal agents. The results indicated that the physicochemical parameters of the AgNPs, including the functional groups present on their surface, interfered with their antifungal activity. Overall, the results indicate that there is no specificity of the AgNPs for the yeasts or for the phytopathogens, which can be an advantage, increasing the possibility of application in different areas.pt_BR
dc.description.sponsorship(FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulopt_BR
dc.format.extent91pt_BR
dc.language.isoEnglishpt_BR
dc.relation.ispartofAntibioticspt_BR
dc.rightsOpen accesspt_BR
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/pt_BR
dc.titleAntifungal activity of mycogenic silver nanoparticles on clinical yeasts and phytopathogenspt_BR
dc.typeArticlept_BR
dc.rights.licenseCC BYpt_BR
dc.identifier.doi10.3390/antibiotics12010091pt_BR
dc.contributor.external(USP) Universidade de São Paulopt_BR
dc.identifier.citationvolume12pt_BR
dc.identifier.citationissue1pt_BR
dc.subject.keywordbiogenic silver nanoparticlespt_BR
dc.subject.keywordphytopathogenspt_BR
dc.subject.keywordCandida sp., antifungal activitypt_BR
dc.relation.ispartofabbreviatedAntibioticspt_BR
dc.identifier.citationabntv. 12, n. 1, 91, jan. 2023pt_BR
dc.identifier.citationvancouver2023 Jan; 12(1):91pt_BR
dc.contributor.butantanConrado, Rafael|:Técnico|:(LDI) Lab. Desenvolvimento e Inovação Industrialpt_BR
dc.contributor.butantanSouza, Ana Olívia de|:Pesquisador|:(LDI) Lab. Desenvolvimento e Inovação Industrial|:Autor de correspondênciapt_BR
dc.sponsorship.butantan(FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulo¦¦2010/50186-5pt_BR
dc.sponsorship.butantan(FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulo¦¦2020/04799-7pt_BR
dc.sponsorship.butantan(FAPESP) Fundação de Amparo à Pesquisa do Estado de São Paulo¦¦2020/03883-4pt_BR
dc.identifier.bvsccBR78.1pt_BR
dc.identifier.bvsdbIBProdpt_BR
dc.description.dbindexedYespt_BR
item.languageiso639-1English-
item.fulltextCom Texto completo-
item.grantfulltextopen-
item.openairetypeArticle-
crisitem.author.dept#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.dept#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.dept#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.dept#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.orcid#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.orcid#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.orcid#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.orcid0000-0001-6025-7500-
crisitem.author.parentorg#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.author.parentorg#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.journal.journalissn#PLACEHOLDER_PARENT_METADATA_VALUE#-
crisitem.journal.journaleissn#PLACEHOLDER_PARENT_METADATA_VALUE#-
Aparece nas Coleções:Artigos


Arquivos neste item

antibiotics-12-00091.pdf
Descrição:
Tamanho: 3.22 MB
Formato: Adobe PDF
Ver/Aberto
Mostrar registro simples do item

Este item está licenciada sob uma Licença Creative Commons Creative Commons